Schedule 13D ownership disclosure

Sionna Therapeutics Inc

Common Stock, $0.001 par value per share · CUSIP: 829401108

Event date: 2025-02-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Enavate Sciences GP, LLCReported CIK 0001953107

    Shares: 2,478,030.00 · Class: 5.6%

  • Sionna Aggregator, LPReported CIK 0002055981

    Shares: 2,478,030.00 · Class: 5.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-004410
Form type
SCHEDULE 13D
Filer
Enavate Sciences GP, LLC
CIK
CIK 1953107
Filed
Feb 18, 2025
Reporting period
Feb 10, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub